H.R. 3537: Accelerating Access to Critical Therapies for ALS Act
Legislation Details
117th Congress
To direct the Secretary of Health and Human Services to support research on, and expanded access to, investigational drugs for amyotrophic lateral sclerosis, and for other purposes.
Sponsor: Rep. Michael Quigley — D — IL
Establishes grant programs to address neurodegenerative diseases, such as amyotrophic lateral sclerosis (also known as ALS or Lou Gehrig's disease), and contains other related provisions. The Department of Health and Human Services (HHS) shall award grants to eligible entities to facilitate patients' access to investigational drugs that diagnose or treat ALS. The Food and Drug Administration (FDA) shall award grants to public and...
JOIN US!
Sign up below to receive updates when your Members of Congress vote for new spending increases or cuts.
Lost your Password?
Don't be sad- we've got your back. Just enter your email below and instructions on resetting your password will be sent to you.
×